Skip to search formSkip to main contentSkip to account menu

balugrastim

National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Granulocyte Colony-Stimulating FactorRecombinant Fusion ProteinsSerum Albumin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Phase II dose-finding study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy
Balugrastim is a once-per-cycle, fixed-dose recombinant protein comprising human serum albumin and granulocyte colony-stimulating… 
2015
2015
First-in-human, phase I/IIa dose-escalation and safety study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy
PurposeTo evaluate safety of balugrastim, a recombinant human serum albumin and granulocyte colony-stimulating factor (G-CSF… 
2011
2011
1216 POSTER Albumin-fusion R-metHuG-CSF (Balugrastim) – a Novel Long-acting Once-per-cycle Fixed Dose Filgrastim: Pharmocokinetics and Pharmacodynamics in Breast Cancer Patients
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)